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Upon reaching the mature heat stable antigen (HSA)
 
low
 
 thymic developmental stage, CD1d-
restricted V
 
 
 
14-J
 
 
 
18 thymocytes undergo a well-characterized sequence of expansion and 
differentiation steps that lead to the peripheral interleukin-4/interferon-
 
 
 
–producing NKT 
phenotype. However, their more immature HSA
 
high
 
 precursors have remained elusive, and it 
has been difficult to determine unambiguously whether NKT cells originate from a CD4
 
 
 
CD8
 
 
 
 
double-positive (DP) stage, and when the CD4
 
 
 
 and CD4
 
 
 
CD8
 
 
 
 double-negative (DN) NKT 
subsets are formed. Here, we have used a CD1d tetramer-based enrichment strategy to 
physically identify HSA
 
high
 
 precursors in thymuses of newborn mice, including an elusive DP
 
low
 
 
stage and a CD4
 
 
 
 stage, which were present at a frequency of 
 
 
 
10
 
 
 
6
 
. These HSA
 
high
 
 DP and 
CD4
 
 
 
 stages appeared to be nondividing, and already exhibited the same V
 
 
 
8 bias that 
characterizes mature NKT cells. This implied that the massive expansion of NKT cells is 
separated temporally from positive selection, but faithfully amplifies the selected TCR 
repertoire. Furthermore, we found that, unlike the DN 
 
  
 
 T cells, the DN NKT cells did not 
originate from a pT
 
 
 
-independent pathway bypassing the DP stage, but instead were 
produced during a short window of time from the conversion of a fraction of HSA
 
low
 
 NK1.1
 
neg
 
 
CD4 cells. These findings identify the HSA
 
high
 
 CD4
 
 
 
 stage as a potential branchpoint between 
NKT and conventional T lineages and between the CD4 and DN NKT sublineages.
 
Mouse V
 
 
 
14-J
 
 
 
18/V
 
 
 
8,V
 
 
 
7,V
 
 
 
2 and human
V
 
 
 
24-J
 
 
 
18/V
 
 
 
11 NKT cells are a conserved
CD1d-restricted innate-like lymphocyte lineage
that is involved in various infectious, allergic,
autoimmune, and tumor conditions through
the recognition of conserved endogenous and
exogenous glycolipids (1–5). These glycolipids
include the self-antigen, iGb3, generated in
lysosomal compartments (4); microbial 
 
 
 
-gly-
curonosylceramides found in the cell wall of
Gram
 
 
 
 LPS
 
 
 
 bacteria (3, 5); and mycobacterial
phosphatidylinositolmannosides (6).
The development of this unusual lineage
has remained largely elusive. Two main models
have been proposed: a precommitment model
(7), which suggests that NKT cells originate from
a committed precursor before TCR expression,
and an instructive model (8) whereby main-
stream thymocytes expressing the rare canonical
CD1d-reactive TCR are instructed—by virtue
of their interaction with CD1d-expressing
cells—to differentiate into NKT cells. In strong
support of the instructive model, transgenic ex-
pression of the canonical NKT cell receptor
was sufficient to induce NKT cell differentiation
(9). In addition, staining with CD1d tetramers
identified developmental intermediates after
positive selection, but preceding the acquisition
of NK differentiation (10, 11). The earliest,
well-characterized precursor identified was
a rare, mature heat stable antigen (HSA)
 
low
 
CD44
 
low
 
 thymocyte with a CD4
 
 
 
 or double-
negative (DN) phenotype. Unlike other mature
thymocytes, this cell seemed to be engaged in
cell cycle, and gave rise to the CD44
 
high
 
memory-type stage. Cycling CD44
 
high
 
 cells
migrated to the periphery where they induced
an “NK program”—including the expression
of NK1.1, Ly49, and CD94/NKG2A—over
the course of several weeks. In parallel with
these phenotypic events, NKT cells acquired
the ability to produce IL-4, then also IFN-
 
 
 
upon TCR stimulation.
The conspicuous activation and expansion
undergone by mature HSA
 
low
 
 NKT thymo-
cytes suggest that they must have received
unusual signals. Unlike mainstream T cells,
NKT development depends on interaction
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with antigen expressed on the surface of bone marrow–
derived cells, including double-positive (DP) thymocytes,
rather than epithelial cells (12–16). Furthermore, recognition
of the endogenous glycosphingolipid iGb3, an agonist anti-
gen for mouse and human NKT cells, also is likely to be in-
volved in the unusual signaling that leads to NKT cell ex-
pansion and differentiation (4). Consistent with the hypothesis
of differential signaling, NKT development is unaffected by
dominant negative forms of Ras or Mek-1 (17), but is abro-
gated completely in Fyn null mice (18, 19). The recent find-
ing that signaling lymphocyte activation molecule (SLAM)–
associated protein (SAP) connects Fyn to SLAM family
members expressed on the cell surface (20–22) suggests that,
in conjunction with TCR signaling, key signals may ema-
nate from homotypic interaction between SLAM family
members expressed by thymocytes (i.e., between the devel-
oping NKT precursors and neighboring CD1d-expressing
DP thymocytes; references 23–26).
Integration of these recent advances in the general
scheme of NKT cell development requires precise character-
ization of the immature HSA
 
high
 
 stages; however, their very
low frequency (estimated at less than 1/10
 
6
 
) has precluded
physical identification. For example, it is unclear whether
NKT cells transit through a DP stage. The existence of very
rare tetramer-positive DP thymocytes is controversial (11,
27, 28). PCR-based studies have revealed rare V
 
 
 
14-J
 
 
 
18
joints among DP thymocytes; however, it has not been de-
termined whether the corresponding cells are enriched in or
deprived of NKT cell precursors because the coexpression of
V
 
 
 
 chains (V
 
 
 
8, V
 
 
 
7, V
 
 
 
2) allowing endogenous ligand
recognition has not been determined (27). In one study, pu-
rified DP thymocytes generated rare mature NKT cells upon
intrathymic transfer; however, the inordinately high number
of cells injected (10
 
7
 
) may have included enough immature
DN cell contaminants to account for NKT cell generation
independent of the DP stage (27).
The origin of the DN sublineage of NKT cells, which is
found in mouse and human, also is elusive. Because DN and
CD4 cells are represented at the first developmental stage
identified, the HSA
 
low
 
 CD44
 
low
 
 cell, it remains unclear
whether DN cells originate early from precursors that bypass
the DP stage (e.g., as is the case for DN 
 
  
 
 T cells), or later
from DP or even from CD4 T cells. Although the CD4 and
CD8 coreceptors are dispensable for the development of the
CD4 and DN NKT sublineages, the absence of CD8 has a
measurable impact on the V
 
 
 
 repertoire of CD4 and DN
cells (12). This suggests that earlier expression of CD8 influ-
ences positive or negative selection, perhaps through inter-
action with CD1d. Transgenic expression of CD8
 
  
 
—
under a CD2 promoter—drastically reduced the thymic NKT
cell population; this also supports the hypothesis that CD8
may interact with CD1d (12). Finally, in mice transgenically
expressing the V
 
 
 
14-J
 
 
 
18 TCR 
 
 
 
 chain, CD8 cells were
depleted of the V
 
 
 
8 and V
 
 
 
7 chains that confer reactivity to
CD1d (9). These findings suggested that the conspicuous ab-
sence of CD8
 
 
 
 NKT cells in WT mice may reflect negative
selection or, as previously observed in a TCR transgenic sys-
tem with agonist ligand signaling (29), the direct transforma-
tion of DP into DN or CD8
 
  
 
 cells.
In this study, we used a CD1d tetramer-based strategy to
enrich NKT cell precursors from the thymus of WT new-
born mice. Comparison with J
 
 
 
18
 
 
 
/
 
 
 
 and CD1d
 
 
 
/
 
 
 
 NKT
deficient controls allowed the identification of rare, noncyc-
ling HSA
 
high
 
 DP
 
low
 
 and HSA
 
high
 
 CD4
 
 
 
 precursors; intrathy-
mic cell transfers demonstrated that the DN subset origi-
nated later from cycling HSA
 
low
 
 CD4 cells. These findings
that identify the early stages of NKT cells in the thymus pro-
vide significant additions to the developmental map of NKT
cells at the cellular level, and have implications on the mo-
lecular mechanisms that underlie this enigmatic pathway of
T cell development.
 
RESULTS
Identification of HSA
 
high
 
 V
 
 
 
14 NKT cells in newborn thymus
 
Because of their massive intrathymic expansion, NKT cells
are readily detectable among adult mature HSA
 
low
 
 thy-
mocytes by specific tetramer staining. In contrast, as shown
in Fig. 1, their frequency among the immature HSA
 
high
 
 pop-
ulation is very low and comparable to that of J
 
 
 
18-deficient
thymuses where the canonical NKT TCR is absent or of
CD1d-deficient thymus where NKT cells are not selected.
This indicates that HSA
 
high
 
 NKT lineage cells are too rare to
be detected over a “nonspecific” staining background of
0.02%. However, upon magnetic-activated cell sorting
(MACS)-enrichment with the same tetramers, bona fide,
predominantly HSA
 
high
 
 tetramer-positive cells were recov-
ered from WT 3-d-old thymuses, but not J
 
 
 
18-deficient or
CD1d-deficient controls (Fig. 2). This result indicates that
the cells that were stained “nonspecifically” by FACS were
not recovered after MACS enrichment, perhaps because of
their lower affinity interactions with the tetramers. Using
this strategy, we were able to enrich the frequency of NKT
lineage cells 
 
 
 
1,000 fold; however, we estimate that under
MACS conditions, only one third of the NKT lineage cells
Figure 1. Detection of HSAhigh NKT lineage cells in total thymocyte 
preparations. Total thymocytes from 2-wk-old WT, J 18 / , and CD1d /  
mice were stained with HSA and CD1d-tetramers. Gates identifying the 
tet HSAlow and tet HSAhigh cells are shown with corresponding frequen-
cies. Note that the level of background staining in the HSAhigh gates (as 
measured in J 18 /  and CD1d /  mice) precludes the identification of 
HSAhigh NKT lineage cells in wild type mice. Data representative of  10 
individual WT or mutant mice. 
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were recovered from these early thymuses. Therefore, the
rarity of these NKT lineage cells in newborns required large-
scale experiments; typically, we pooled 40–60 newborn thy-
muses to enrich and examine 
 
 
 
200–300 “authentic” tet
 
 
 
cells, because the procedure recovered approximately one
NKT cell per 10
 
6
 
 thymocytes at this age (Table I). In these
3-d-old mice, 
 
 
 
70% of the tet
 
 
 
 cells, on average, were
composed of HSA
 
high
 
 cells (Fig. 2 and Table I), whereas the
average proportion decreased to 57% at day 4, 13% at day 5,
and 2% at day 8 (Fig. 3 and Table I). Nearly all of the
tet
 
 
 
HSA
 
high
 
 cells found in 3-d-old mice were CD4  (Fig. 2).
Rare other cells included DPlow cells that could not be dis-
tinguished readily from the background staining of control
J 18 /  thymuses. In older newborn mice, the HSAhigh cells
were largely of the CD4  phenotype, although minor pro-
portions of DN cells could be detected (Fig. 3). In contrast,
in the same tetramer-enriched population, the tet HSAlow
cells were composed of nearly equal proportions of CD4 
and DN cells as early as day 3 of age (Figs. 2 and 3). As
shown in Figs. 2 and 3, HSAhigh CD4  cells were absent
from the thymus of CD1d-deficient mice, which supports
the notion that they are the product of positive selection.
Given the extreme rarity of the HSAhigh CD4  cell, it is
not surprising that we could not detect earlier stages, such as
putative DP precursors. The lower TCR level and lower
frequency of these precursors likely renders them undetect-
able. A population of DPlow cells belonging to the NKT lin-
eage became visible at 2 wk of age (Fig. 3). A similar pheno-
type had been reported previously (27, 28), but was not
confirmed in a subsequent study (11). Therefore, it was not
clear whether these rare, unusual cells were bona fide NKT
lineage cells or a staining artifact. The absence of DPlow cells
in J 18 /  mice (Fig. 3) indicates that they represent an au-
thentic NKT lineage cell type, and their appearance at 2
weeks may help to explain seemingly contradictory reports.
Their similar frequency to HSAhigh CD4  cells suggests that
they are a product of positive selection, as confirmed by their
absence in the CD1d /  thymus. In addition, the DPlow
phenotype was identical to that of CD69  DP thymocytes
previously associated with positive selection (30; see the po-
sition of the pink gate in Figs. 3 and 4). The absence of this
phenotype in younger mice may reflect different kinetics in
the down-regulation of the CD4 and CD8 coreceptors and
regulation of TCR following positive selection.
Figure 2. Improved detection of HSAhigh NKT lineage cells in 
MACS-enriched thymocyte preparations. Thymocytes from 3-d-old 
WT, J 18 / , and CD1d /  mice were MACS-enriched for tet  cells and 
stained for HSA, CD4, and CD8. The left column shows CD1d-tetramer/
HSA staining of MACS-enriched preparations, the other columns show 
CD4/CD8 staining of whole thymocytes, or MACS-enriched thymocytes 
in the R1 (HSAlow) and R2 (HSAhigh) gates, as indicated. The numbers on the 
HSA/CD1d-tetramers dot plots represent the percentages of HSAlow and 
HSAhigh cells among the tet  population. The numbers on the R1 and R2 
gated CD4/CD8 FACS dot plots represent the percentage of CD4  and DN 
populations among HSAlow and HSAhigh NKT lineage cells. Note that in the 
tet  MACS-enriched panels, each dot represents a cell: there were 3 and 5 
tet  dots in the MACS-enriched preparations of J 18 /  and CD1d /  
thymuses, respectively, and 224 tet  dots in the WT. Data are representa-
tive of at least three individual experiments with pooled thymuses from 
40 to 60 3-d-old newborns.
Table I. Ontogeny of NKT lineage thymocytes
Frequency 
among 
total thymocytesc
Frequency
among 
tet cells
Day
Total 
thymocyte no.a
tet  cells 
recovered/thymusb HSAhigh HSAlow HSAhigh
 106  10 7 %
3 12   38    3 3.5   1.5 1.5   1 70.5   4.5
4 18   2 10   1 2.5   0.5 2   0.5 57.5   7.5
5 25   4 38   5 2.8   1 16   2.5 13   3
8 37   2 3,729   70 16   4 982   52 1.5   0.5
aMeans   SD are calculated from at least three separate experiments using pools of 
up to 40–60 newborn thymuses.
btet  cells were counted after MACS enrichment. Only approximately one third of 
the tet  cells were recovered by this method in 8-d-old thymuses.
cCalculated based on tet  cells recovered after MACS.EARLY THYMOCYTE PRECURSOR TO NKT CELL | Benlagha et al. 488
HSAhigh V 14 NKT cells are not cycling and express 
a biased V 8 usage
Mature HSAlow NKT cells are large, cycling cells that char-
acteristically undergo multiple rounds of cell division that
lead to massive intrathymic expansion (10). We found that
the size of the HSAhigh cells, both DPlow and CD4, was com-
parable to that of the majority of thymocytes, and much
smaller than the cycling HSAlow cell (Fig. 4 A). Although the
rarity of these cell types precludes BrdU incorporation stud-
ies, their small size likely reflects the lack of cell cycling. This
is consistent with the lack of expansion of this population af-
ter birth, compared with the explosive growth of HSAlow
cells between days 5 and 8 (Table I). Thus, cell division is a
late event that can be separated from the stages of develop-
ment. The HSAhigh DP and HSAhigh CD4 cells expressed a
CD44low NK1.1  phenotype similar to that of the following
HSAlow stage (Fig. 4 B). In addition, they expressed CD69,
as reported for cells having recently undergone positive se-
lection (30).
Mature HSAlow NKT cells express a highly biased rep-
ertoire overusing V 8, V 7, and V 2; however, it is un-
clear whether this V  hierarchy results from preferential
expansion at mature stages or from preferential selection at
immature stages. Although the CD1d- -galactosylceramide
(CD1d- -GalCer) tetramers may bias the analysis to cells
expressing these three V  chains, Fig. 4 B shows that the
HSAhigh cells exhibited the same frequency of V 8 chain
usage as found in the HSAlow stages. This result suggests
that the hierarchy of V  chain usage, at least among the
three V  families, is already established after positive selec-
tion and is not modified substantially later by preferential
cellular expansion.
Figure 3. Ontogeny of HSAhigh and HSAlow NKT lineage thymocytes. 
Thymocytes of WT mice at different ages were enriched and analyzed as in 
Fig. 2. The total numbers of MACS-enriched tet  cells at 4 and 5 d was 208 
and 265, respectively (note that all dots are displayed and each dot repre-
sents a cell). Tet  DPlow cells are in the pink elliptic gate and have the same 
DPlow phenotype as the CD69  DP cells in the total thymocyte population 
shown in the rightmost panel of fourth row. Note that for consistency of 
CD4/CD8 staining, thymuses at 8 d, 14 d, and 5 weeks were analyzed side 
by side in the same experiment (rows 3–5), with doublet and propidium 
iodide uptake exclusion. The 2-wk-old thymocytes also were analyzed side 
by side with J 18 /  and CD1d /  thymuses in the same experiment 
(bottom three rows). Data are representative of at least three individual 
experiments where 5 to 60 thymuses were pooled.JEM VOL. 202, August 15, 2005 489
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DN cells arise from CD4 cells at the HSAlow NK1.1  stage
The exclusive CD4  phenotype of the HSAhigh stage and the
appearance of DN cells at the cycling HSAlow CD44low stage
suggested that DN cells might arise at this latter stage from
CD4  precursors. We sorted the CD4  subset of thymic
HSAlow NK1.1  tet  cells from WT mice and injected it
into the thymus of J 18 /  (NKT-deficient) recipients. In
this transfer assay, the transferred NK1.1  cells matured to
NK1.1  within 5–7 d, as previously shown. In addition, the
progeny of the CD4 subset included CD4  and DN cells
(Fig. 5 A), which demonstrated a precursor product relation-
ship between CD4 and DN cells. A similar relationship was
suggested previously (11). In contrast, the mature NK1.1 
cells conserved their CD4 or DN phenotype in the same in-
trathymic transfer conditions (Fig. 5 A). To rule out poten-
tial artifacts caused by tetramer staining, we sorted CD4 
CD44highNK1.1  cells from a preparation of HSAlowCD8neg
thymocytes, and transferred them intrathymically. The prog-
eny of the CD4  cells contained CD4  and DN tet  NKT
cells (Fig. 5 B). Together, these results demonstrate that DN
cells arise from the conversion of CD4  cells during a short
developmental window.
DN NKT cells do not arise through a pT -independent 
“  -like” pathway
It was hypothesized that a proportion of DN NKT cells
might originate through a distinct pT -independent “  -
like” pathway that is characterized by the absence of induc-
tion of CD4 or CD8 coreceptor. Although pT -deficient
mice have normal    T cell compartments, they were re-
Figure 4. Phenotypic characterization of HSAhigh NKT cells. Thy-
mocytes were MACS-enriched for tet  cells and (A) analyzed for size 
(forward scatter, FSC) and granularity (side scatter, SSC) or (B) stained for 
HSA, CD44, NK1.1, V 8, or CD69. Line graphs display the frequency of 
CD44 , NK1.1 , V 8 , and CD69  cells among tet HSAlow or tet HSAhigh 
cells gated as indicated. Data are representative of three individual experi-
ments using pools of 7-d-old or 2-wk-old mice as indicated.EARLY THYMOCYTE PRECURSOR TO NKT CELL | Benlagha et al. 490
ported to lack NKT cells, a finding that apparently is incon-
sistent with the hypothesis (31). However, it is recognized
that the NKT cell defect in these mice might not be cell au-
tonomous, but could be secondary to the profound deple-
tion of thymocytes acting as CD1d-presenting cells for
NKT cell selection. Therefore, we generated mixed, con-
genically marked pT  / :WT into irradiated J 18 / 
recipient bone marrow radiation chimeras. Fig. 6 dem-
onstrates that, in contrast with WT NKT cells, which
developed normally, there was a profound, cell autonomous
NKT cell defect in the CD45.1  pT  /  compartment of
these mixed chimeras.
DISCUSSION
By enriching NKT precursors from pools of up to 60 new-
born thymuses with CD1d- -GalCer tetramers and MACS
sorting, we have been able to identify and characterize very
rare (10 6) HSAhigh cells that represent the earliest reported
stages of NKT cell development (10, 11, 27, 28). The physi-
cal identification of the HSAhigh DPlow and HSAhigh CD4 
stages essentially completes the map of this enigmatic devel-
opmental pathway (Fig. 7). The nearly exclusive CD4  phe-
notype of the rare HSAhigh precursor in 3-d-old mice, and the
demonstration by cell transfer experiments that the CD4 
cells could give rise to a substantial fraction of DN cells clearly
support a model whereby all DN cells arise late in develop-
ment, after down-regulation of CD4 by a fraction of CD4 
cells. However, the presence of rare DN cells among the
HSAhigh subset of older mice and the appearance of a popula-
tion of DPlow cells in 2-wk-old mice suggest that the respec-
tive kinetics of CD4/CD8 coreceptor down-modulation may
vary with age, and that commitment to the CD4 versus DN
sublineage already may be imparted at a DP stage. The exist-
ence of DPlow cells has been controversial (11, 27, 28). Our
results differ markedly from those of Gapin et al. (27) and Ga-
due et al. (28) who found relatively high frequencies of DPlow
cells among total tet  thymocytes. Instead, we found that au-
thentic DPlow cells were very rare, and were restricted to the
previously unrecognized HSAhigh stage of development.
This study could not detect tet  DP thymocytes preced-
ing positive selection in CD1d /  mice. However, the un-
ambiguous presence of DPlow cells after positive selection is
important because it provides critical and direct evidence for
the existence of such a DP precursor stage. Other experi-
mental results support this conclusion. For example, the cell-
autonomous requirement for pT , as demonstrated in the
present study, is highly suggestive of such a stage because
pT  signaling induces CD4 and CD8 expression. The ge-
netic role of CD8 in shaping the V  repertoire of CD4 and
DN NKT cells also suggests their previous expression of
CD8, and its interaction with CD1d (12). Finally, it was
shown recently in a TCR transgenic model of agonist-medi-
ated selection that immature DP cells could give rise to ma-
ture DN or CD8   cells, a direct demonstration of the
down-regulation of CD4 and CD8  (29). This example is
particularly relevant to the development of NKT cells, be-
Figure 5. DN NKT cells arise from CD4  precursors. NKT thymocyte 
subsets were isolated and FACS-sorted from 2–4-wk-old mice for intrathymic 
injection into NKT-deficient J 18 /  recipients. The subsets injected included 
(A) tet NK1.1 CD4 , tet NK1.1 CD4 , and tet NK1.1 CD4  (as gated) or 
(B) CD4 CD44highNK1.1  cells (as gated) obtained from a preparation of 
HSAlowCD8-negative IA b /  thymocytes without tetramer staining. CD4/
NK1.1 profiles of sorted cells and their progeny 7 d after intrathymic injec-
tion are shown, as indicated. Numbers represent the percentages of each 
subpopulation in indicated gate or quadrant. Data are representative of 
three separate experiments.
Figure 6. Cell-autonomous requirement for pT  in NKT thymocyte 
development. Mature NKT cells in WT, pT  / , and pT  / :WT bone 
marrow → J 18 /  radiation chimeras. In the mixed chimera, the WT 
compartment is identified by CD45.2 gating and the pT  /  compartment 
by CD45.1 as indicated. Data are representative of at least four mice in 
each group.JEM VOL. 202, August 15, 2005 491
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cause their thymic ligand, iGb3, also is an agonist that is ca-
pable of full activation of mature cells.
Given the rarity of the HSAhigh DPlow and HSAhigh CD4 
cell, it may not be surprising that, for technical reasons, prese-
lection DP precursors would not be detected. The rarity of
these precursors also supports the notion that canonical V 14-
J 18 rearrangements occur stochastically at very low frequency.
It remains unclear what determines the CD4 versus DN
fate of NKT cells. Their near 1:1 ratio might suggest a sto-
chastic decision; however, an alternative model is that CD8
could be forcibly down-regulated from DP cells undergoing
high levels of signaling. The CD4 versus DN choice also
might be instructed by different TCR affinities for ligand.
The newly identified HSAhigh DPlow and HSAhigh CD4 
cells have a small size and express CD69. These stages, which
precede the previously identified HSAlow CD4  at which cells
blast and undergo intense cell division, are analogous to the
HSAhigh CD69  stage following positive selection of main-
stream MHC-restricted T cells (30). These positively selected
MHC-restricted T cells will not engage in cell cycle. Thus,
the HSAhigh CD4  cell represents the likely branchpoint in
the development of mainstream T versus NKT cells. An unre-
solved issue is whether commitment to cell division already is
imparted at this stage, or whether it occurs later at the HSAlow
stage (e.g., upon second antigenic stimulation by medullary
dendritic cells). Although there is no example, to our knowl-
edge, of mitogenic stimuli imparted at the immature HSAhigh
stage, some arguments suggest that this may be the case. First,
entry into the cell cycle is delayed by 1 or 2 d following TCR
stimulation, corresponding to the lag time between HSAhigh
and HSAlow CD4 T cells. Second, recent experiments have
demonstrated that restricted expression of CD1d on DP thy-
mocytes was sufficient to drive the major expansion observed
at the medullary HSAlow stage (32).
These different lines of evidence raise the surprising pos-
sibility that a single set of signaling interactions between
HSAhigh NKT cell precursors and neighboring cortical thy-
mocytes—involving TCR and perhaps SLAM family mem-
bers as coreceptors—may represent the defining event of the
NKT lineage imparting the subsequent NKT expansion and
differentiation program.
MATERIALS AND METHODS
Mice. C57BL/6, C57BL/6.CD45.2, and C57BL/6.I-A b /  mice were
obtained from Taconic Farms. CD1d /  mice were used after 12 back-
crosses to C57BL/6 (33). J 18 /  (34) and pT  /  (35) mice on C57BL/6
backgrounds were gifts from M. Taniguchi (RIKEN, Yokohama, Japan)
and I. Aifantis (University of Chicago, Chicago, IL), respectively. All mice
were maintained under specific pathogen-free conditions at the University
of Chicago, and experimental studies were in accordance with the Institu-
tional Animal Care and Use Guidelines.
Flow cytometry. FITC-conjugated mAbs against CD8, V 8.1/8.2,
CD45.2, CD4, CD24 (HSA), CD44, and CD69; PE-conjugated mAbs against
CD69, HSA, CD44, and NK1.1; PE-Cy7–conjugated mAb against CD4; cy-
chrome-conjugated mAbs against CD24, CD4, and CD8; and allophycocya-
nin-conjugated mAbs against CD4, CD44, CD8, and NK1.1 were obtained
from BD Biosciences. Propidium iodide was from Sigma-Aldrich. CD1d-
 -GalCer tetramers were produced with streptavidin-PE or -allophycocyanin
and used for staining as described previously (36). Samples were analyzed using
a four-color FACSort equipped with argon and 635-nm diode lasers (Becton
Dickinson) and CELLQuest software. For five-color staining, samples were
analyzed using BD LSR II equipped with 488 sapphire and 633 HeNe lasers
(Becton Dickinson) and FACSDiva software. In some experiments, doublet
and propidium iodide exclusion was applied to remove irrelevant dots.
Enrichment of CD1d- GalCer tetramer  cells with paramagnetic
microbeads. Thymuses were pooled from batches of 40 to 60 newborns
(day of birth considered as day 1), and CD1d tetramer  thymocytes were
enriched using anti-PE or -allophycocyanin microbeads and the Au-
toMACs system (Miltenyi Biotec) at ice cold temperature following the
manufacturer’s instructions.
FACS sorting of NKT cells. Pooled thymuses from batches of 25 to 50
C57BL/6.IA b /  or C57BL/6 mice (2–4-wk-old) were depleted of
CD8  cells using anti-CD8 microbeads and the AutoMACs system (Milte-
nyi Biotec); stained with CD1d- GalCer streptavidin-PE along with anti-
CD4 and -NK1.1; and the NKT cells were sorted into CD4 NK1.1 ,
CD4 NK1.1 , and CD4 NK1.1  subsets. Alternatively, to avoid TCR
cross-linking by tetramer staining, CD8-negative thymocyte preparations
were stained with HSA, CD4, CD44, and NK1.1 for sorting of
HSAlowCD4 CD44highNK1.1  cells.
Intrathymic injection. Sorted tetramer-positive CD4 NK1.1 , CD4 
NK1.1 , and CD4 NK1.1  subsets or sorted CD4 CD44highNK1.1  cells
(4–8   105) were injected intrathymically as described, and their progeny
were analyzed 5 to 7 d later after MACS enrichment of CD1d-tetramer
positive cells.
Bone marrow radiation chimeras. C57BL/6.J 18 /  mice received
whole body  -irradiation (1,000 Rad) with a cesium source (Gammacell
40), and were reconstituted 6 h later with one i.v. injection of 5–10   106
bone marrow cells from various adult donors.
We thank R. Duggan, J. Marvin, and B. Eisfelder (Flow Cytometry Facility) for cell 
sorting, and all Bendelac lab members for expert advice and discussion.
This work is supported by a special fellowship from the Leukemia and 
Figure 7. New model outlining the cellular developmental stages leading to mature CD4 and DN NKT cells. The dashed arrows indicate hypo-
thetical precursor–product relationship.EARLY THYMOCYTE PRECURSOR TO NKT CELL | Benlagha et al. 492
Lymphoma Society (to K. Benlagha) and by National Institutes of Health grant no. 
RO1 AI 38339 (to A. Bendelac).
The authors have no conflicting financial interests.
Submitted: 1 March 2005
Accepted: 1 July 2005
REFERENCES
1. Park, S.H., and A. Bendelac. 2000. CD1-restricted T-cell responses
and microbial infection. Nature. 406:788–792.
2. Godfrey, D.I., K.J. Hammond, L.D. Poulton, M.J. Smyth, and A.G.
Baxter. 2000. NKT cells: facts, functions and fallacies. Immunol. Today.
21:573–583.
3. Kinjo, Y., D. Wu, G. Kim, G.W. Xing, M.A. Poles, D.D. Ho, M.
Tsuji, K. Kawahara, C.H. Wong, and M. Kronenberg. 2005. Recog-
nition of bacterial glycosphingolipids by natural killer T cells. Nature.
434:520–525.
4. Zhou, D., J. Mattner, C. Cantu III, N. Schrantz, N. Yin, Y. Gao, Y.
Sagiv, K. Hudspeth, Y.P. Wu, T. Yamashita, et al. 2004. Lysosomal
glycosphingolipid recognition by NKT cells. Science. 306:1786–1789.
5. Mattner, J., K.L. DeBord, N. Ismail, R.D. Goff, C. Cantu III, D.
Zhou, P. Saint-Mezard, V. Wang, Y. Gao, N. Yin, et al. 2005. Both
exogenous and endogenous glycolipid antigens activate NKT cells dur-
ing microbial infections. Nature. 434:525–529.
6. Fischer, K., E. Scotet, M. Niemeyer, H. Koebernick, J. Zerrahn, S.
Maillet, R. Hurwitz, M. Kursar, M. Bonneville, S.H. Kaufmann, and
U.E. Schaible. 2004. Mycobacterial phosphatidylinositol mannoside is
a natural antigen for CD1d-restricted T cells. Proc. Natl. Acad. Sci.
USA. 101:10685–10690.
7. Makino, Y., R. Kanno, H. Koseki, and M. Taniguchi. 1996. Develop-
ment of Valpha4  NK T cells in the early stages of embryogenesis.
Proc. Natl. Acad. Sci. USA. 93:6516–6520.
8. Bendelac, A., M.N. Rivera, S.-H. Park, and J.H. Roark. 1997. Mouse
CD1-specific NK1 T cells. Development, specificity, and function.
Annu. Rev. Immunol. 15:535–562.
9. Bendelac, A., R.D. Hunziker, and O. Lantz. 1996. Increased interleu-
kin 4 and immunoglobulin E production in transgenic mice overex-
pressing NK1 T cells. J. Exp. Med. 184:1285–1293.
10. Benlagha, K., T. Kyin, A. Beavis, L. Teyton, and A. Bendelac. 2002. A
thymic precursor to the NKT cell lineage. Science. 296:553–555.
11. Pellicci, D.G., K.J. Hammond, A.P. Uldrich, A.G. Baxter, M.J.
Smyth, and D.I. Godfrey. 2002. A natural killer T (NKT) cell develop-
mental pathway involving a thymus-dependent NK1.1(-)CD4( )
CD1d-dependent precursor stage. J. Exp. Med. 195:835–844.
12. Bendelac, A., N. Killeen, D. Littman, and R.H. Schwartz. 1994. A
subset of CD4  thymocytes selected by MHC class I molecules. Sci-
ence. 263:1774–1778.
13. Bix, M., M. Coles, and D. Raulet. 1993. Positive selection of Vb8 
CD4-8- thymocytes by class I molecules expressed by hematopoietic
cells. J. Exp. Med. 178:901–908.
14. Coles, M.C., and D.H. Raulet. 2000. NK1.1  T cells in the liver arise
in the thymus and are selected by interactions with class I molecules on
CD4 CD8  cells. J. Immunol. 164:2412–2418.
15. Bendelac, A. 1995. Positive selection of mouse NK1  T cells by
CD1-expressing cortical thymocytes. J. Exp. Med. 182:2091–2096.
16. Ohteki, T., and H.R. MacDonald. 1994. Major histocompatibility
complex class I related molecules control the development of CD4 8-
and CD4-8- subsets of natural killer 1.1  T cell receptor-a/b  cells in
the liver of mice. J. Exp. Med. 180:699–704.
17. Alberola-Ila, J., K.A. Hogquist, K.A. Swan, M.J. Bevan, and R.M.
Perlemutter. 1996. Positive and negative selection invoke distinct sig-
naling pathways. J. Exp. Med. 184:9–18.
18. Gadue, P., N. Morton, and P.L. Stein. 1999. The Src family tyrosine
kinase Fyn regulates natural killer T cell development. J. Exp. Med.
190:1189–1196.
19. Eberl, G., B. Lowin-Kropf, and H.R. MacDonald. 1999. Cutting
edge: NKT cell development is selectively impaired in Fyn-deficient
mice. J. Immunol. 163:4091–4094.
20. Sayos, J., C. Wu, M. Morra, N. Wang, X. Zhang, D. Allen, S. van
Schaik, L. Notarangelo, R. Geha, M.G. Roncarolo, et al. 1998. The
X-linked lymphoproliferative-disease gene product SAP regulates sig-
nals induced through the co-receptor SLAM. Nature. 395:462–469.
21. Chan, B., A. Lanyi, H.K. Song, J. Griesbach, M. Simarro-Grande, F.
Poy, D. Howie, J. Sumegi, C. Terhorst, and M.J. Eck. 2003. SAP cou-
ples Fyn to SLAM immune receptors. Nat. Cell Biol. 5:155–160.
22. Latour, S., R. Roncagalli, R. Chen, M. Bakinowski, X. Shi, P.L.
Schwartzberg, D. Davidson, and A. Veillette. 2003. Binding of SAP
SH2 domain to FynT SH3 domain reveals a novel mechanism of re-
ceptor signalling in immune regulation. Nat. Cell Biol. 5:149–154.
23. Chung, B., A. Aoukaty, J. Dutz, C. Terhorst, and R. Tan. 2005. Sig-
naling lymphocytic activation molecule-associated protein controls
NKT cell functions. J. Immunol. 174:3153–3157.
24. Nichols, K.E., J. Hom, S.Y. Gong, A. Ganguly, C.S. Ma, J.L. Can-
nons, S.G. Tangye, P.L. Schwartzberg, G.A. Koretzky, and P.L. Stein.
2005. Regulation of NKT cell development by SAP, the protein de-
fective in XLP. Nat. Med. 11:340–345.
25. Pasquier, B., L. Yin, M.C. Fondaneche, F. Relouzat, C. Bloch-Quey-
rat, N. Lambert, A. Fischer, G. de Saint-Basile, and S. Latour. 2005.
Defective NKT cell development in mice and humans lacking the
adapter SAP, the X-linked lymphoproliferative syndrome gene prod-
uct. J. Exp. Med. 201:695–701.
26. Borowski, C., and A. Bendelac. 2005. Signaling for NKT cell develop-
ment: the SAP-Fyn connection. J. Exp. Med. 201:833–836.
27. Gapin, L., J.L. Matsuda, C.D. Surh, and M. Kronenberg. 2001. NKT
cells derive from double-positive thymocytes that are positively se-
lected by CD1d. Nat. Immunol. 2:971–978.
28. Gadue, P., and P.L. Stein. 2002. NK T cell precursors exhibit differen-
tial cytokine regulation and require Itk for efficient maturation. J. Im-
munol. 169:2397–2406.
29. Yamagata, T., D. Mathis, and C. Benoist. 2004. Self-reactivity in thy-
mic double-positives commits cells to a CD8   lineage with charac-
teristics of innate immune cells. Nat. Immunol. 5:597–605.
30. Bendelac, A., P. Matzinger, R.A. Seder, W.E. Paul, and R.H.
Schwartz. 1992. Activation events during thymic selection. J. Exp.
Med. 175:731–742.
31. Eberl, G., H.J. Fehling, H. von Boehmer, and H.R. MacDonald.
1999. Absolute requirement for the pre-T cell receptor alpha chain
during NK1.1  TCRalphabeta cell development. Eur. J. Immunol. 29:
1966–1971.
32. Wei, D.G., H. Lee, S.H. Park, L. Beaudoin, L. Teyton, A. Lehuen,
and A. Bendelac. 2005. Expansion and long range differentiation of the
NKT lineage in mice expressing CD1d exclusively on cortical thy-
mocytes. J. Exp. Med. 202:239–248.
33. Park, S.H., D. Guy-Grand, F.A. Lemonnier, C.R. Wang, A. Bendelac,
and B. Jabri. 1999. Selection and expansion of CD8alpha/alpha(1) T
cell receptor alpha/beta(1) intestinal intraepithelial lymphocytes in the
absence of both classical major histocompatibility complex class I and
nonclassical CD1 molecules. J. Exp. Med. 190:885–890.
34. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko,
H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for
Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science.
278:1623–1626.
35. Fehling, H.J., A. Krotkova, C. Saint-Ruf, and H. von Boehmer. 1995.
Crucial role of the pre-T-cell receptor alpha gene in development of
alpha beta but not gamma delta T cells. Nature. 375:795–798.
36. Benlagha, K., A. Weiss, A. Beavis, L. Teyton, and A. Bendelac. 2000.
In vivo identification of glycolipid antigen specific T cells using fluo-
rescent CD1d tetramers. J. Exp. Med. 191:1895–1903.